Hypera SA (HYPMY) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · United States · ISIN US44914U1060

Price
27.78 USD
Market cap
17.68 bn USD
P/E (2025)
14.79
P/S (2025)
2.30
Dividend yield
3.93 %
Net margin
15.53 %
Return on equity (ROE)
9.55 %
Return on assets (ROA)
4.75 %

Hypera SA financials

Fiscal year20242025
Revenue7.44 bn BRL7.70 bn BRL
Gross profit4.38 bn BRL4.55 bn BRL
Operating income1.80 bn BRL1.74 bn BRL
EBIT1.95 bn BRL1.94 bn BRL
Net income1.34 bn BRL1.20 bn BRL
Diluted EPS – continuing operations2.10 BRL1.88 BRL

Full history since 2005, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Hypera SA

Hypera S.A. operates as a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands; analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands; cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Coristina, APRACUR, and Fluviral brands. It offers antihistamines products under Alektos, Histamin, Polaramine, PredSim, and Desrinite brands; antiseptics products under Merthiolate brand; Herbal medicine products under Maracugina, Eparema, Tamarine, and Naturetti brands; gastrointestinal products under Dramin, Estomazil, Engov, Lacto-purga, gastrol, Epocler, Bifilax, and Pepsamar brands. In addition, the company provides generics products under neo quimica brand; skicare products under episol, epidrat, simple organic, and bioage brands; supplements and vitamins products Addera, Biotonico Fontoura, Colflex, and Vitasay brands; and other products under Nebacetin, Cepacol, ESCABIN, Mirrorelax, Ammy, Nesina, and Diprospan brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.